Skip to content

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine

2023092815090-f43a05437ad630b99d72021937860037da802fe91fcf2cefbd456fd6fc970e28
Health Canada has authorized Pfizer-BioNTech's updated COVID-19 vaccine for people six months and older. A nurse administers a Pfizer COVID-19 booster vaccine in Jackson, Miss., Friday, Nov. 18, 2022. THE CANADIAN PRESS/AP/Rogelio V. Solis

OTTAWA — Health Canada has authorized Pfizer-BioNTech's updated COVID-19 vaccine for people six months and older.  

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada. 

This is the second vaccine targeting XBB.1.5 that will be available in this country. 

Earlier this month, Health Canada authorized Moderna's updated mRNA vaccine.

Both Pfizer and Moderna's shots are one-dose vaccines for people five years of age and older.

Three shots of the Pfizer vaccine is recommended for children between six months and four years of age who have not received their primary series of a COVID-19 vaccine.  

Health Canada says it is currently reviewing an updated non-mRNA vaccine from Novavax. 

Novavax's vaccine has been submitted for consideration in people 12 years of age and older. 

This report by The Canadian Press was first published Sept. 28, 2023.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian Press


Looking for National News?

VillageReport.ca viewed on a mobile phone

Check out Village Report - the news that matters most to Canada, updated throughout the day.  Or, subscribe to Village Report's free daily newsletter: a compilation of the news you need to know, sent to your inbox at 6AM.

Subscribe